Health Catalyst Capital

Health Catalyst Capital, established in 2015 and based in New York, is a venture capital firm that invests in high-growth U.S.-based healthcare technology companies. It focuses on themes with the potential to reach $1 billion in enterprise value, targeting investments ranging from $1 million to $20 million. The firm, a Registered Investment Adviser, seeks to back innovative businesses in the information technology and technology-enabled service sectors within the healthcare industry.

Joseph Boorady

Senior Operating Partner

Peter Costa

Operating Partner

30 past transactions

Glooko

Series F in 2024
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Cylinder

Series B in 2023
Vivante Health, Inc. is a digital health company focused on addressing digestive health and chronic conditions. Founded in 2016, it has developed GIThrive, a technology platform designed to provide actionable insights for managing digestive issues. GIThrive offers a comprehensive digital gut health program that includes expert guidance, 24/7 support, and personalized care plans. The company also provides GIMate, an innovative portable breathalyzer that identifies trigger foods, and GutCheck, which analyzes gut bacteria to recommend tailored diets. Vivante Health emphasizes individualized care, utilizing a scalable platform that integrates real-time data from biometric devices and partners. This approach not only aims to reduce healthcare costs and improve employee health for large employers and health plans but also enhances user empowerment through advanced science and technology. Headquartered in Houston, Texas, with an additional office in Athens, Greece, Vivante Health continues to prioritize innovative solutions in the realm of digestive health.

Clearsense

Series D in 2023
Clearsense, LLC is a healthcare technology company based in Jacksonville, Florida, founded in 2013. The company specializes in providing a cloud-based data platform that offers healthcare analytics and data management solutions for organizations and patients. Its platform, known as the Clearsense Data Management Platform, aggregates and manages data from various sources, facilitating real-time insights into clinical, operational, and financial metrics. By converting disparate data into a single source of truth, Clearsense enhances data maturity and optimizes analytics tools, ultimately improving decision-making and driving meaningful outcomes. The platform is designed to be secure and scalable, empowering healthcare organizations to leverage their data effectively, reduce costs, and seize new revenue opportunities.

ReferWell

Series B in 2023
ReferWell is a healthcare technology company that offers a cloud-based platform designed to address the challenges associated with care transitions. By connecting healthcare providers into Virtually Integrated Networks, ReferWell enhances the patient journey through better visibility and management of all interactions. The platform facilitates streamlined referrals, point-of-care appointment scheduling, and supports care teams with tools like provider directory management and telehealth capabilities. This comprehensive suite of services enables healthcare providers and networks to improve patient compliance, reduce leakage, and close care gaps, ultimately leading to increased revenue and enhanced patient outcomes.

Holmusk

Series B in 2023
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.

Holmusk

Venture Round in 2021
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.

PierianDx

Venture Round in 2021
PierianDx, Inc. is a biotechnology company that specializes in developing a cloud-based genomic software solution aimed at managing, analyzing, and interpreting complex genomic tests for clinical laboratories in the United States. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx offers its Clinical Genomicist Workstation, which streamlines the workflow for patient cases, encompassing aspects from case accessioning to final report generation and integration with electronic health records. The company's software employs artificial intelligence to enhance the efficiency of genomic sequencing processes, thereby empowering healthcare providers to better diagnose and treat patients with cancer and other complex diseases. PierianDx also provides consulting and technical services, and collaborates strategically with organizations like RTI International. Through its accredited laboratory and extensive knowledgebase, the company supports health systems, children's hospitals, comprehensive cancer centers, and commercial laboratories in delivering integrated genomic care.

Click Therapeutics

Series B in 2021
Click Therapeutics, Inc. is a New York-based company that specializes in the engineering, validation, development, and commercialization of digital therapeutics aimed at addressing unmet medical needs through cognitive and neurobehavioral modification. Founded in 2012, Click Therapeutics focuses on creating software-based medical treatments for various conditions, including smoking cessation, major depressive disorders, schizophrenia, insomnia, and chronic pain. Its innovative Digital Therapeutics™ can be utilized independently or alongside traditional biomedical treatments, enhancing patient engagement and treatment outcomes. The company's Clickometrics® adaptive data science platform personalizes user experiences to optimize results. Notably, Click's smoking cessation program has successfully launched nationwide, and its leading prescription program is currently undergoing a phase III FDA registration trial for treating Major Depressive Disorder in adults.

Ilumivu

Series A in 2021
Ilumivu, established in 2009, specializes in healthcare decision support applications that leverage the psychology of behavior change alongside real-time data from smartphones and wearables. The company is dedicated to improving patient care outcomes through just-in-time adaptive interventions tailored to individual baselines. Ilumivu's digital health platform is utilized for monitoring various health conditions, including diabetes, sleep apnea, hypertension, and chronic diseases such as Alzheimer’s and cancer. With a foundation in extensive research from over 100 leading universities and health systems, Ilumivu supports healthcare research through its software as a service (SaaS) solutions. In 2021, the company expanded its offerings by acquiring Cardiogram, a heart health app that utilizes a neural network to analyze cardiovascular data, aiding users in identifying conditions such as atrial fibrillation and hypertension. The Cardiogram app is compatible with multiple smartphone operating systems and wearable devices, boasting over 2.6 million downloads globally.

Pager

Series C in 2021
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Clearsense

Venture Round in 2021
Clearsense, LLC is a healthcare technology company based in Jacksonville, Florida, founded in 2013. The company specializes in providing a cloud-based data platform that offers healthcare analytics and data management solutions for organizations and patients. Its platform, known as the Clearsense Data Management Platform, aggregates and manages data from various sources, facilitating real-time insights into clinical, operational, and financial metrics. By converting disparate data into a single source of truth, Clearsense enhances data maturity and optimizes analytics tools, ultimately improving decision-making and driving meaningful outcomes. The platform is designed to be secure and scalable, empowering healthcare organizations to leverage their data effectively, reduce costs, and seize new revenue opportunities.

Glooko

Series D in 2021
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Insightin Health

Series A in 2021
Insightin Health is a technology company that develops a cloud-based platform designed to automate preventative care recommendations within healthcare systems. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the company offers its inGAGE™ platform, which integrates medical, clinical, cognitive, and social determinants of health to deliver personalized care suggestions. This AI-driven platform supports healthcare organizations in member acquisition, retention, and engagement by providing real-time actionable analytics and campaign automation. By centralizing member activities, Insightin Health enables health plans to enhance quality measurements, boost member satisfaction, and reduce churn rates. The company's solutions cater to various markets, including Medicare/Medicaid, accountable care organizations, and broker/agent networks.

Holmusk

Series A in 2020
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.

ReferWell

Venture Round in 2020
ReferWell is a healthcare technology company that offers a cloud-based platform designed to address the challenges associated with care transitions. By connecting healthcare providers into Virtually Integrated Networks, ReferWell enhances the patient journey through better visibility and management of all interactions. The platform facilitates streamlined referrals, point-of-care appointment scheduling, and supports care teams with tools like provider directory management and telehealth capabilities. This comprehensive suite of services enables healthcare providers and networks to improve patient compliance, reduce leakage, and close care gaps, ultimately leading to increased revenue and enhanced patient outcomes.

Pager

Series B in 2020
Pager, Inc. is a company that operates an on-demand service platform designed to connect patients with healthcare services in various settings including homes, offices, and hotels. The company offers a mobile application that facilitates access to urgent care for a range of conditions such as infections, respiratory issues, and allergies. In addition to its core services, Pager provides nurse chat, teleconsultation, screening, vaccination, and prescription delivery. The company's mission focuses on improving healthcare accessibility, lowering costs, and simplifying care navigation through a flexible platform that integrates artificial intelligence and service teams. Amidst its extensive offerings, Pager supports over 15 million individuals across the United States and Latin America, enabling coordinated care that enhances patient engagement and decision-making. Incorporated in 2013 and headquartered in New York, Pager was previously known as techCare, Inc. before rebranding in 2014.

Risalto

Series A in 2019
Risalto Health, established in 2016 and headquartered in New York, specializes in streamlining musculoskeletal care through a data-driven platform. It connects patients, care providers, and concierges, utilizing big data and analytics to assemble multidisciplinary teams for back, neck, knee, and hip pain treatment. Risalto aims to improve patient outcomes, reduce costs, and enhance care efficiency by directing patients to evidence-based, high-quality providers.

PierianDx

Series B in 2019
PierianDx, Inc. is a biotechnology company that specializes in developing a cloud-based genomic software solution aimed at managing, analyzing, and interpreting complex genomic tests for clinical laboratories in the United States. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx offers its Clinical Genomicist Workstation, which streamlines the workflow for patient cases, encompassing aspects from case accessioning to final report generation and integration with electronic health records. The company's software employs artificial intelligence to enhance the efficiency of genomic sequencing processes, thereby empowering healthcare providers to better diagnose and treat patients with cancer and other complex diseases. PierianDx also provides consulting and technical services, and collaborates strategically with organizations like RTI International. Through its accredited laboratory and extensive knowledgebase, the company supports health systems, children's hospitals, comprehensive cancer centers, and commercial laboratories in delivering integrated genomic care.

Insightin Health

Seed Round in 2019
Insightin Health is a technology company that develops a cloud-based platform designed to automate preventative care recommendations within healthcare systems. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the company offers its inGAGE™ platform, which integrates medical, clinical, cognitive, and social determinants of health to deliver personalized care suggestions. This AI-driven platform supports healthcare organizations in member acquisition, retention, and engagement by providing real-time actionable analytics and campaign automation. By centralizing member activities, Insightin Health enables health plans to enhance quality measurements, boost member satisfaction, and reduce churn rates. The company's solutions cater to various markets, including Medicare/Medicaid, accountable care organizations, and broker/agent networks.

Clareto

Series A in 2019
Clareto is a health information exchange company founded in 2000 and based in Richmond, Virginia. It specializes in connecting the life insurance industry with patient-authorized health information. By leveraging its health information technology, Clareto bridges the gap between healthcare and life insurance, facilitating the electronic exchange of health data. The company engages with health information exchanges, healthcare providers, and various data sources to enhance the flow of health information. This capability supports the life insurance sector in critical processes such as underwriting and claims management, ultimately streamlining operations and improving data accessibility.

Medal

Venture Round in 2019
Medal, Inc. is a healthcare company based in San Francisco, California, that specializes in providing administrator services. Established in 2015, the company focuses on the extraction, transportation, translation, and sharing of medical information. Medal’s services facilitate the efficient review, coordination, referral, analysis, billing, and auditing of healthcare data. As of July 2020, Medal operates as a subsidiary of CIOX Health, enhancing its capabilities in the healthcare information management sector.

Simplifeye

Venture Round in 2019
Simplifeye, Inc. is a provider of practice management software solutions focused on enhancing patient engagement and communication for healthcare providers. Incorporated in 2014 and based in New York, the company offers a suite of tools including Amplify, a HIPAA-compliant live chat platform that supports multilingual interactions and analyzes patient traffic; Connect, which facilitates telehealth conferencing and streamlines the collection of patient information; and a Scheduling tool that allows patients to book appointments directly. Simplifeye's software is designed to improve patient management and productivity, enabling healthcare practices to capture leads, access patient records efficiently, and enhance overall workflow. The company's solutions cater primarily to medical professionals across the retail healthcare sector.

Sibly

Venture Round in 2018
Sibly, Inc. is a behavioral artificial intelligence company that has developed a health platform focused on mental and behavioral health. Founded in 2016 and based in Redwood City, California, Sibly aims to provide accessible and effective mental health care through a text-based service that connects employees with compassionate human coaches. The platform employs scientifically-supported techniques, including reflective listening and cognitive behavioral strategies, to ensure timely and appropriate support. With a 24/7 coaching team and oversight from licensed therapists, Sibly enhances employee well-being by addressing the diverse health and wellness needs of large organizations. The company seeks to improve engagement with existing benefits while fostering personal connections that empower users to better understand themselves and enhance their overall mental health.

Risalto

Seed Round in 2018
Risalto Health, established in 2016 and headquartered in New York, specializes in streamlining musculoskeletal care through a data-driven platform. It connects patients, care providers, and concierges, utilizing big data and analytics to assemble multidisciplinary teams for back, neck, knee, and hip pain treatment. Risalto aims to improve patient outcomes, reduce costs, and enhance care efficiency by directing patients to evidence-based, high-quality providers.

Insightin Health

Seed Round in 2018
Insightin Health is a technology company that develops a cloud-based platform designed to automate preventative care recommendations within healthcare systems. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the company offers its inGAGE™ platform, which integrates medical, clinical, cognitive, and social determinants of health to deliver personalized care suggestions. This AI-driven platform supports healthcare organizations in member acquisition, retention, and engagement by providing real-time actionable analytics and campaign automation. By centralizing member activities, Insightin Health enables health plans to enhance quality measurements, boost member satisfaction, and reduce churn rates. The company's solutions cater to various markets, including Medicare/Medicaid, accountable care organizations, and broker/agent networks.

Cardiogram

Venture Round in 2018
Cardiogram, Inc. is a San Francisco-based company founded in 2015 that specializes in developing a wearable device for monitoring heart health. The company's application allows users to analyze and visualize their heart rate measurements, tracking responses to various activities such as exercise, stress, and dietary changes. By detecting heartbeats and monitoring sleep and fitness patterns, Cardiogram aims to empower users to prevent serious cardiovascular issues, including strokes. The application is compatible with devices equipped with heart rate monitors, such as the Apple Watch and Android Wear, and facilitates the sharing of heart rate data through various social media platforms.

BetterDoctor

Series B in 2017
BetterDoctor, Inc. is a technology company based in San Francisco, founded in 2011, that focuses on improving healthcare access by providing web and mobile applications for users to find doctors. Its platform allows individuals to search for healthcare providers based on their specific needs and insurance plans, offering a directory of verified doctors. BetterDoctor also serves health plans and systems by validating and delivering accurate provider data through its API, supporting numerous companies and developers in enhancing their healthcare offerings. By enabling real-time appointment scheduling and ensuring the accuracy of doctor information, BetterDoctor aims to simplify the process of finding qualified healthcare professionals, thereby improving patient outcomes. As of June 2018, BetterDoctor operates as a subsidiary of Quest Analytics, L.L.C.

ReferWell

Private Equity Round in 2016
ReferWell is a healthcare technology company that offers a cloud-based platform designed to address the challenges associated with care transitions. By connecting healthcare providers into Virtually Integrated Networks, ReferWell enhances the patient journey through better visibility and management of all interactions. The platform facilitates streamlined referrals, point-of-care appointment scheduling, and supports care teams with tools like provider directory management and telehealth capabilities. This comprehensive suite of services enables healthcare providers and networks to improve patient compliance, reduce leakage, and close care gaps, ultimately leading to increased revenue and enhanced patient outcomes.

PierianDx

Series A in 2016
PierianDx, Inc. is a biotechnology company that specializes in developing a cloud-based genomic software solution aimed at managing, analyzing, and interpreting complex genomic tests for clinical laboratories in the United States. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx offers its Clinical Genomicist Workstation, which streamlines the workflow for patient cases, encompassing aspects from case accessioning to final report generation and integration with electronic health records. The company's software employs artificial intelligence to enhance the efficiency of genomic sequencing processes, thereby empowering healthcare providers to better diagnose and treat patients with cancer and other complex diseases. PierianDx also provides consulting and technical services, and collaborates strategically with organizations like RTI International. Through its accredited laboratory and extensive knowledgebase, the company supports health systems, children's hospitals, comprehensive cancer centers, and commercial laboratories in delivering integrated genomic care.

PierianDx

Series A in 2015
PierianDx, Inc. is a biotechnology company that specializes in developing a cloud-based genomic software solution aimed at managing, analyzing, and interpreting complex genomic tests for clinical laboratories in the United States. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx offers its Clinical Genomicist Workstation, which streamlines the workflow for patient cases, encompassing aspects from case accessioning to final report generation and integration with electronic health records. The company's software employs artificial intelligence to enhance the efficiency of genomic sequencing processes, thereby empowering healthcare providers to better diagnose and treat patients with cancer and other complex diseases. PierianDx also provides consulting and technical services, and collaborates strategically with organizations like RTI International. Through its accredited laboratory and extensive knowledgebase, the company supports health systems, children's hospitals, comprehensive cancer centers, and commercial laboratories in delivering integrated genomic care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.